CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist
  • 72.66
  • +1.67+2.35%
Market Closed Apr 18 15:00 CST
5.76BMarket Cap-77297P/E (TTM)

Hangzhou Alltest Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Total operating revenue
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
628.17%2.1B
64.98%1.87B
63.37%996.86M
30.48%635.57M
Operating revenue
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
628.17%2.1B
64.98%1.87B
63.37%996.86M
30.48%635.57M
Total operating cost
-68.81%437.85M
-73.52%305.91M
-77.30%178.93M
73.28%1.75B
213.10%1.4B
347.60%1.16B
592.03%788.2M
193.69%1.01B
156.46%448.32M
121.98%258.09M
Operating cost
-73.04%291.66M
-77.73%207.1M
-83.44%111.69M
61.64%1.36B
232.59%1.08B
411.45%929.81M
714.02%674.49M
316.72%839.93M
247.20%325.28M
173.06%181.8M
Operating tax surcharges
-81.79%3.7M
-81.94%2.6M
-4.97%1.59M
180.28%27.82M
66.65%20.33M
140.14%14.37M
-26.30%1.67M
-6.24%9.93M
96.22%12.2M
980.39%5.99M
Operating expense
-64.18%47.45M
-68.30%32.64M
-60.92%16.67M
202.12%150.34M
338.21%132.46M
465.45%102.98M
598.56%42.67M
50.53%49.76M
66.64%30.23M
41.02%18.21M
Administration expense
-25.79%48.45M
-11.59%34.46M
-10.72%18.17M
138.61%78.06M
154.18%65.29M
102.79%38.98M
203.58%20.35M
30.76%32.72M
43.49%25.69M
46.19%19.22M
Financial expense
22.50%-43.11M
-19.01%-36.77M
-344.00%-5.32M
-300.76%-70.93M
-393.75%-55.62M
-496.50%-30.9M
217.24%2.18M
-195.13%-17.7M
-359.84%-11.26M
-237.47%-5.18M
-Interest expense (Financial expense)
-35.03%1.17M
-32.15%833.66K
-41.46%442.38K
224.69%2.17M
--1.8M
--1.23M
--755.67K
--668.76K
----
----
-Interest Income (Financial expense)
9.24%-29.49M
-37.90%-21.8M
-104.40%-8.45M
-13.14%-42.89M
-75.79%-32.49M
-11.59%-15.81M
-840.22%-4.13M
-3,919.66%-37.9M
-2,325.09%-18.48M
-2,302.72%-14.16M
Research and development
-43.72%89.69M
-34.08%65.88M
-22.89%36.12M
117.16%207.3M
140.80%159.38M
162.69%99.94M
162.93%46.84M
73.22%95.46M
91.69%66.19M
54.62%38.04M
Credit Impairment Loss
-103.75%-14.11M
-72.34%-10.77M
-85.30%-7.81M
17.91%-5.56M
-281.11%-6.93M
-110.04%-6.25M
-48.54%-4.21M
-48.39%-6.77M
-73.17%-1.82M
-5.89%-2.97M
Asset Impairment Loss
101.48%1.05M
106.72%4.78M
76.00%-17.06M
-7,016.09%-280.06M
-4,577.25%-71.08M
-1,870.70%-71.08M
-5,762.74%-71.08M
-50.22%-3.94M
3,887.25%1.59M
-129.75%-3.61M
Adjustment items of total operating cost
----
----
---0.01
----
----
----
----
----
----
----
Other net revenue
Fair value change income
-83.25%4.96M
-90.61%1.41M
--9.53M
-171.36%-15.22M
--29.63M
--15.01M
----
--21.33M
--0
----
Invest income
-56.10%6.34M
-49.29%6.26M
61.98%4.66M
246.83%24.12M
114.33%14.45M
130.20%12.35M
-23.56%2.88M
34.00%6.95M
115.89%6.74M
451.08%5.37M
Asset deal income
-3,438.20%-535.17K
-489,844.80%-535.17K
-774,917.52%-846.55K
1,004.34%533.17K
-44.92%16.03K
-100.38%-109.23
-100.38%-109.23
---58.96K
-50.65%29.11K
-50.65%29.11K
Other revenue
-64.22%9.3M
-56.58%7.99M
-85.47%576.47K
99.67%31.75M
372.85%26M
371.73%18.4M
1,484.45%3.97M
412.10%15.9M
80.51%5.5M
905.96%3.9M
Adjusted Items effecting operating profit
----
----
---0.01
----
----
----
----
----
----
----
Operating profit
-91.92%129.1M
-94.07%91.08M
-96.28%46.25M
55.43%1.39B
185.14%1.6B
304.20%1.54B
612.55%1.24B
13.12%896.75M
27.23%560.58M
3.35%380.2M
Add:Non operating Income
-98.54%13.97K
-95.06%13.97K
-99.47%842.15
114.87%125.17K
2,573.07%957.06K
314,461,866.67%283.02K
263,909,500.00%158.35K
388.02%58.26K
199.95%35.8K
-100.00%0.09
Less:Non operating expense
45.09%14.15M
48.33%13.83M
-96.34%200.11K
879.44%12.51M
688.68%9.75M
817.50%9.32M
547,267,166.00%5.47M
18.98%1.28M
18.92%1.24M
0.78%1.02M
Total profit
-92.77%114.96M
-94.94%77.26M
-96.28%46.06M
54.26%1.38B
184.18%1.59B
302.90%1.53B
609.50%1.24B
13.12%895.53M
27.25%559.38M
3.35%379.18M
Less:Income tax cost
-94.01%13.72M
-97.14%6.44M
-96.95%5.72M
51.29%196.43M
197.07%228.93M
323.76%224.93M
680.56%187.83M
15.48%129.84M
24.45%77.06M
2.03%53.08M
Net profit
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.76%1.19B
182.12%1.36B
299.51%1.3B
598.12%1.05B
12.73%765.69M
27.71%482.32M
3.57%326.1M
Net profit from continuing operation
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.76%1.19B
182.12%1.36B
299.51%1.3B
598.12%1.05B
12.73%765.69M
27.71%482.32M
3.57%326.1M
Less:Minority Profit
-283.53%-319.37K
-506.30%-355K
-120.88%-196.37K
--538.05K
--174.02K
--87.37K
---88.9K
----
----
----
Net profit of parent company owners
-92.53%101.57M
-94.54%71.18M
-96.14%40.53M
54.69%1.18B
182.09%1.36B
299.48%1.3B
598.18%1.05B
12.73%765.69M
27.71%482.32M
3.57%326.1M
Earning per share
Basic earning per share
-92.54%1.28
-94.52%0.9
-96.15%0.75
45.02%21.97
79.31%17.16
137.43%16.43
423.12%19.46
-9.93%15.15
2.35%9.57
-11.17%6.92
Diluted earning per share
--1.28
--0.9
--0.75
--21.97
----
----
----
----
----
----
Other composite income
-86.50%3.88M
-66.90%4.76M
-410.05%-280.66K
21,705.78%28.12M
16,975.15%28.78M
24,772.44%14.38M
3,247.81%90.52K
-44.21%128.98K
103.57%168.55K
211.40%57.8K
Other composite income of parent company owners
-86.52%3.88M
-66.93%4.75M
-464.00%-339.7K
21,710.09%28.13M
16,983.33%28.79M
24,772.44%14.38M
3,345.32%93.32K
-44.21%128.98K
103.57%168.55K
211.40%57.8K
Other composite income of minority owners
119.25%2.65K
--4.23K
2,205.68%59.05K
---5.56K
---13.79K
----
---2.8K
----
----
----
Total composite income
-92.43%105.13M
-94.26%75.59M
-96.18%40.06M
58.41%1.21B
187.99%1.39B
303.85%1.32B
598.20%1.05B
12.71%765.82M
27.73%482.48M
3.60%326.16M
Total composite income of parent company owners
-92.41%105.45M
-94.23%75.94M
-96.17%40.19M
58.34%1.21B
187.96%1.39B
303.82%1.32B
598.26%1.05B
12.71%765.82M
27.73%482.48M
3.60%326.16M
Total composite income of minority owners
-297.67%-316.72K
-501.46%-350.77K
-49.74%-137.33K
--532.49K
--160.23K
--87.37K
---91.71K
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Total operating revenue -81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B628.17%2.1B64.98%1.87B63.37%996.86M30.48%635.57M
Operating revenue -81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B628.17%2.1B64.98%1.87B63.37%996.86M30.48%635.57M
Total operating cost -68.81%437.85M-73.52%305.91M-77.30%178.93M73.28%1.75B213.10%1.4B347.60%1.16B592.03%788.2M193.69%1.01B156.46%448.32M121.98%258.09M
Operating cost -73.04%291.66M-77.73%207.1M-83.44%111.69M61.64%1.36B232.59%1.08B411.45%929.81M714.02%674.49M316.72%839.93M247.20%325.28M173.06%181.8M
Operating tax surcharges -81.79%3.7M-81.94%2.6M-4.97%1.59M180.28%27.82M66.65%20.33M140.14%14.37M-26.30%1.67M-6.24%9.93M96.22%12.2M980.39%5.99M
Operating expense -64.18%47.45M-68.30%32.64M-60.92%16.67M202.12%150.34M338.21%132.46M465.45%102.98M598.56%42.67M50.53%49.76M66.64%30.23M41.02%18.21M
Administration expense -25.79%48.45M-11.59%34.46M-10.72%18.17M138.61%78.06M154.18%65.29M102.79%38.98M203.58%20.35M30.76%32.72M43.49%25.69M46.19%19.22M
Financial expense 22.50%-43.11M-19.01%-36.77M-344.00%-5.32M-300.76%-70.93M-393.75%-55.62M-496.50%-30.9M217.24%2.18M-195.13%-17.7M-359.84%-11.26M-237.47%-5.18M
-Interest expense (Financial expense) -35.03%1.17M-32.15%833.66K-41.46%442.38K224.69%2.17M--1.8M--1.23M--755.67K--668.76K--------
-Interest Income (Financial expense) 9.24%-29.49M-37.90%-21.8M-104.40%-8.45M-13.14%-42.89M-75.79%-32.49M-11.59%-15.81M-840.22%-4.13M-3,919.66%-37.9M-2,325.09%-18.48M-2,302.72%-14.16M
Research and development -43.72%89.69M-34.08%65.88M-22.89%36.12M117.16%207.3M140.80%159.38M162.69%99.94M162.93%46.84M73.22%95.46M91.69%66.19M54.62%38.04M
Credit Impairment Loss -103.75%-14.11M-72.34%-10.77M-85.30%-7.81M17.91%-5.56M-281.11%-6.93M-110.04%-6.25M-48.54%-4.21M-48.39%-6.77M-73.17%-1.82M-5.89%-2.97M
Asset Impairment Loss 101.48%1.05M106.72%4.78M76.00%-17.06M-7,016.09%-280.06M-4,577.25%-71.08M-1,870.70%-71.08M-5,762.74%-71.08M-50.22%-3.94M3,887.25%1.59M-129.75%-3.61M
Adjustment items of total operating cost -----------0.01----------------------------
Other net revenue
Fair value change income -83.25%4.96M-90.61%1.41M--9.53M-171.36%-15.22M--29.63M--15.01M------21.33M--0----
Invest income -56.10%6.34M-49.29%6.26M61.98%4.66M246.83%24.12M114.33%14.45M130.20%12.35M-23.56%2.88M34.00%6.95M115.89%6.74M451.08%5.37M
Asset deal income -3,438.20%-535.17K-489,844.80%-535.17K-774,917.52%-846.55K1,004.34%533.17K-44.92%16.03K-100.38%-109.23-100.38%-109.23---58.96K-50.65%29.11K-50.65%29.11K
Other revenue -64.22%9.3M-56.58%7.99M-85.47%576.47K99.67%31.75M372.85%26M371.73%18.4M1,484.45%3.97M412.10%15.9M80.51%5.5M905.96%3.9M
Adjusted Items effecting operating profit -----------0.01----------------------------
Operating profit -91.92%129.1M-94.07%91.08M-96.28%46.25M55.43%1.39B185.14%1.6B304.20%1.54B612.55%1.24B13.12%896.75M27.23%560.58M3.35%380.2M
Add:Non operating Income -98.54%13.97K-95.06%13.97K-99.47%842.15114.87%125.17K2,573.07%957.06K314,461,866.67%283.02K263,909,500.00%158.35K388.02%58.26K199.95%35.8K-100.00%0.09
Less:Non operating expense 45.09%14.15M48.33%13.83M-96.34%200.11K879.44%12.51M688.68%9.75M817.50%9.32M547,267,166.00%5.47M18.98%1.28M18.92%1.24M0.78%1.02M
Total profit -92.77%114.96M-94.94%77.26M-96.28%46.06M54.26%1.38B184.18%1.59B302.90%1.53B609.50%1.24B13.12%895.53M27.25%559.38M3.35%379.18M
Less:Income tax cost -94.01%13.72M-97.14%6.44M-96.95%5.72M51.29%196.43M197.07%228.93M323.76%224.93M680.56%187.83M15.48%129.84M24.45%77.06M2.03%53.08M
Net profit -92.56%101.25M-94.56%70.83M-96.16%40.34M54.76%1.19B182.12%1.36B299.51%1.3B598.12%1.05B12.73%765.69M27.71%482.32M3.57%326.1M
Net profit from continuing operation -92.56%101.25M-94.56%70.83M-96.16%40.34M54.76%1.19B182.12%1.36B299.51%1.3B598.12%1.05B12.73%765.69M27.71%482.32M3.57%326.1M
Less:Minority Profit -283.53%-319.37K-506.30%-355K-120.88%-196.37K--538.05K--174.02K--87.37K---88.9K------------
Net profit of parent company owners -92.53%101.57M-94.54%71.18M-96.14%40.53M54.69%1.18B182.09%1.36B299.48%1.3B598.18%1.05B12.73%765.69M27.71%482.32M3.57%326.1M
Earning per share
Basic earning per share -92.54%1.28-94.52%0.9-96.15%0.7545.02%21.9779.31%17.16137.43%16.43423.12%19.46-9.93%15.152.35%9.57-11.17%6.92
Diluted earning per share --1.28--0.9--0.75--21.97------------------------
Other composite income -86.50%3.88M-66.90%4.76M-410.05%-280.66K21,705.78%28.12M16,975.15%28.78M24,772.44%14.38M3,247.81%90.52K-44.21%128.98K103.57%168.55K211.40%57.8K
Other composite income of parent company owners -86.52%3.88M-66.93%4.75M-464.00%-339.7K21,710.09%28.13M16,983.33%28.79M24,772.44%14.38M3,345.32%93.32K-44.21%128.98K103.57%168.55K211.40%57.8K
Other composite income of minority owners 119.25%2.65K--4.23K2,205.68%59.05K---5.56K---13.79K-------2.8K------------
Total composite income -92.43%105.13M-94.26%75.59M-96.18%40.06M58.41%1.21B187.99%1.39B303.85%1.32B598.20%1.05B12.71%765.82M27.73%482.48M3.60%326.16M
Total composite income of parent company owners -92.41%105.45M-94.23%75.94M-96.17%40.19M58.34%1.21B187.96%1.39B303.82%1.32B598.26%1.05B12.71%765.82M27.73%482.48M3.60%326.16M
Total composite income of minority owners -297.67%-316.72K-501.46%-350.77K-49.74%-137.33K--532.49K--160.23K--87.37K---91.71K------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg